Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Almac Expands UK Commercial Capacity | Contract Pharma

What are you searching for?

Sign in
Breaking News

Almac Expands UK Commercial Capacity

Acquires new blistering technology

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Almac has expanded its MHRA/FDA-approved UK commercial packaging facility with the acquisition of a Noack N 623 blister packaging line from Romaco. The line accommodates enhanced flexibility for larger blister sizes and multi unit blister formats, coupled with a requirement for non-permeability and enhanced environmental protection.
 
This cGMP-compliant technology can be configured to process both thermoform and coldform materials, with maximum blister sizes of 220mm x 155mm. The Noack N 623 has an automatic feeding system, filling inspection and ejection station and shorter set-up times. It can process more than 25,000 blisters per hour, including multi-product blisters.
 
“Blister size and dosage formats are becoming increasingly more complex. Additionally, product handling for innovative new molecules often requires enhanced environmental controls. This investment allows Almac, through its Pharma Services business unit, to offer this additional flexibility,” said Geoff Sloan vice president of manufacturing operations. “Through this acquisition, coupled with our immanent entry into the U.S. commercial packaging market, we continue to expand our capabilities and flexibility to meet our client’s needs.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics